Literature DB >> 15915505

Estimating cell death in G(2)M using bivariate BrdUrd/DNA flow cytometry.

R Allen White1, David M Asmuth, Ying Lu, Nan Wang, Xiao-Dong Li, Lisa Reece, Richard B Pollard, Mostafa Nokta, James F Leary, Nicholas H A Terry.   

Abstract

BACKGROUND: In an accompanying paper (Asmuth et al.) it was found necessary to include cell death explicitly to estimate parameters of cell proliferation. The use of bivariate flow cytometry to estimate the phase durations and the doubling times of cells labeled with thymidine analogues is well established. However, these methods of analysis do not consider the possibility of cell death. This report demonstrates that estimating cell death in G(2)/M is possible.
METHODS: Mathematical models for the experimental quantities, the fraction of labeled undivided cells, the fraction of labeled divided cells, and the relative movement were developed. These models include the possibility that, of the cells with G(2)/M DNA content, only a certain fraction will divide, with the remainder dying after some time T(R). Simulation studies were conducted to test the possibility of using simple methods to estimate phase durations and cell death rates.
RESULTS: Cell death alters the estimates of phase transit times in a rather complex manner that depends on the lifetime of the doomed cells. However, it is still possible to obtain estimates of the phase durations of cells in S and G(2)/M and the death rates of cells in G(2)/M.
CONCLUSIONS: The methods presented herein provide a new way to characterize cell populations that includes cell death rates and common measurements of cell proliferation. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15915505     DOI: 10.1002/cyto.a.20147

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  1 in total

1.  A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.

Authors:  Rimantas Eidukevicius; Dainius Characiejus; Ramunas Janavicius; Nijole Kazlauskaite; Vita Pasukoniene; Mykolas Mauricas; Willem Den Otter
Journal:  BMC Cancer       Date:  2005-09-22       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.